Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.64 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.63 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.63 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.61 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.61 |
| ▸ | TACR1 | P25103 | 4/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.57 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.57 |
| ▸ | ITGAL | P20701 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20356918 | 1.00 | KMT2A (0.64) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL22292158 | 1.00 | KMT2A (0.64) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL9088495 | 0.86 | TACR1 (0.64) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL9088492 | 0.86 | TACR1 (0.64) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL14565643 | 0.86 | KMT2A (0.60) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL1921333 | 0.85 | NPC1 (0.62) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL1921332 | 0.85 | NPC1 (0.62) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL13606614 | 0.85 | NPC1 (0.62) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL15145383 | 0.84 | KMT2A (0.66) | KMT2AMEN1HCRTR1NPBWR1MCHR1 | |
| SCHEMBL15145386 | 0.84 | KMT2A (0.65) | KMT2AMEN1HCRTR1NPBWR1MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3345910-B1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2023-11-01 | — | — | EP | claimed |
| CN-108602837-B | Compound having platelet aggregation inhibitory effect, salt thereof, and composition for preventing or treating thrombotic diseases comprising same | 新丰制药株式会社 | 2022-02-11 | — | — | CN | claimed |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | claimed |
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2018-09-06 | — | — | US | claimed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | claimed |
| EP-3345910-B1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2023-11-01 | — | — | EP | disclosed |
| EP-3345910-B1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2023-11-01 | — | — | EP | disclosed |
| CN-108602837-B | Compound having platelet aggregation inhibitory effect, salt thereof, and composition for preventing or treating thrombotic diseases comprising same | 新丰制药株式会社 | 2022-02-11 | — | — | CN | disclosed |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2018-09-06 | — | — | US | disclosed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | disclosed |
| EP-3345910-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | Shin Poong Pharmaceutical Co., Ltd. (KR) | 2018-07-11 | — | — | EP | disclosed |
| WO-2017039395-A1 | COMPOUND HAVING EFFECT OF INHIBITING PLATELET AGGREGATION AND SALT THEREOF, AND COMPOSITION FOR PREVENTING OR TREATING THROMBOTIC DISEASES, CONTAINING SAME | 신풍제약 주식회사 | 2017-03-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180251472-A1 | Compound Having Effect Of Inhibiting Platelet Aggregation And Salt Thereof, And Composition For Preventing Or Treating Thrombotic Diseases, Containing Same | PLA2G7, JAK2, PF4 | KMT2A 3505/4885MEN1 2227/4885HCRTR1 4825/4885 |
| US-10730886-B2 | Compound having effect of inhibiting platelet aggregation and salt thereof, and composition for preventing or treating thrombotic diseases, containing same | PLA2G7, JAK2, PF4 | KMT2A 3505/4885MEN1 2227/4885HCRTR1 4825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.